Effect of the combination therapy of sorafenib and radiofrequency ablation on the survival time of advanced HCC.
Nanya Wang
No relevant relationships to disclose
Wei Li
No relevant relationships to disclose
Hengjun Zhao
No relevant relationships to disclose
Jiuwei Cui
No relevant relationships to disclose